MSC-Delivered Soluble TRAIL and Paclitaxel as Novel Combinatory Treatment for Pancreatic Adenocarcinoma

Pancreatic cancer is the fourth leading cause of cancer death in western countries with more than 100,000 new cases per year in Europe and a mortality rate higher than 90%. In this scenario, advanced therapies based on gene therapies are emerging, thanks to a better understanding of tumour architect...

詳細記述

保存先:
書誌詳細
出版年:Theranostics
主要な著者: Rossignoli, Filippo, Spano, Carlotta, Grisendi, Giulia, Foppiani, Elisabetta Manuela, Golinelli, Giulia, Mastrolia, Ilenia, Bestagno, Marco, Candini, Olivia, Petrachi, Tiziana, Recchia, Alessandra, Miselli, Francesca, Rovesti, Giulia, Orsi, Giulia, Veronesi, Elena, Medici, Gregorio, Petocchi, Benedetta, Pinelli, Massimo, Horwitz, Edwin M., Conte, Pierfranco, Dominici, Massimo
フォーマット: Artigo
言語:Inglês
出版事項: Ivyspring International Publisher 2019
主題:
Research Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6376176/
https://ncbi.nlm.nih.gov/pubmed/30809285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.27576
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料